Rajneet K. Oberoi - Concepedia

Author

Rajneet K. Oberoi

Also Known As

Kazuaki Chayama, R. K. Oberoi, R.K. Oberoi, Rahul Oberoi, Rajneet K Oberoi, Rajneet K. Oberoi, Rajneet Oberoi, Tamara Braut

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

AbbVie (United States)University of Minnesota Hiroshima University Hospital Toranomon Hospital St. Marianna University School of Medicine

About

Rajneet K. Oberoi is an author at AbbVie (United States) specializing in pharmacology, medicine, and bioanalysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	193
2	Pharmacology	7	7	193
3	Neurology	1	1	30
4	Neuroscience	1	1	16
5	Autoimmune Disease	1	1	29

Rajneet K. Oberoi

Publications

886

Citations

H-Index

Page 1

	Year	Citations
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings Murielle M. Véniant, Shu-Chen Lu, Larissa Atangan, Nature Metabolism	2024	160
Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection Hiromitsu Kumada, Tsunamasa Watanabe, Fumitaka Suzuki, Journal of Gastroenterology	2017	115
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis Kazuaki Chayama, Fumitaka Suzuki, Yoshiyasu Karino, Journal of Gastroenterology	2017	114
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection Hidenori Toyoda, Kazuaki Chayama, Fumitaka Suzuki, Hepatology	2017	112
Pharmacokinetic Assessment of Efflux Transport in Sunitinib Distribution to the Brain Rajneet K. Oberoi, Rajendar K. Mittapalli, William F. Elmquist Journal of Pharmacology and Experimental Therapeutics	2013	72
Brain Metastases from Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors Arkadiusz Z. Dudek, Ahmad Raza, Ming Chi, Clinical Genitourinary Cancer Neuro-oncologyUrologyOncologyTumor InnervationBrain Metastases	2012	50
Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastoma Chani Marie Becker, Rajneet K. Oberoi, S. Joey McFarren, Neuro-Oncology	2015	39
A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects Rajneet K. Oberoi, Weihan Zhao, Dilraj S. Sidhu, Journal of Pharmaceutical Sciences Pharmaceutical ScienceHealthy SubjectsPharmacological StudyExcipientsGlecaprevir/pibrentasvir Tablets	2018	36
Sunitinib LC–MS/MS Assay in Mouse Plasma and Brain Tissue: Application in CNS Distribution Studies Rajneet K. Oberoi, Rajendar K. Mittapalli, James Fisher, Chromatographia Neuro-oncologySunitinib Lc–ms/ms AssayCns Distribution StudiesMedicineMouse Plasma	2013	30
Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis Amit Khatri, Doerthe Eckert, Rajneet K. Oberoi, The Journal of Clinical Pharmacology White Healthy SubjectsTranslational MedicineAutoimmune DiseaseGeneralized Pustular PsoriasisRisankizumab Exposures	2019	29

Page 1